본문으로 건너뛰기
← 뒤로

Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.

1/5 보강
Surgery today 2026 Inflammatory Biomarkers in Disease P
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-30
OpenAlex 토픽 · Inflammatory Biomarkers in Disease Prognosis Gastric Cancer Management and Outcomes Nutrition and Health in Aging

Matsunaga T, Saito H, Fukumoto Y, Kuroda H, Taniguchi K, Takahashi S, Osaki T, Iwamoto A, Fukuda K, Shimizu S, Shishido Y, Miyatani K, Sakamoto T, Fujiwara Y

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Tomoyuki Matsunaga, Hiroaki Saito, et al. (2026). Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.. Surgery today. https://doi.org/10.1007/s00595-026-03296-y
MLA Tomoyuki Matsunaga, et al.. "Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.." Surgery today, 2026.
PMID 41961260

같은 제1저자의 인용 많은 논문 (5)